DFTX

Definium Therapeutics, Inc. - Common Shares (DFTX)

About Definium Therapeutics, Inc. - Common Shares (DFTX)

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Details

Daily high

$46.37

Daily low

$44.19

Price at open

$45.34

52 Week High

$49.70

52 Week Low

$8.70

Market cap

6.1B

Dividend yield

Volume

2.0M

Avg. volume

2.2M

P/E ratio

-13.16

Definium Therapeutics, Inc. - Common Shares News